M, F., N, R., & JM, S. (2025). Engineered N-TIMP2 Variant Specifically Targeting MMP-9 Exhibits Potent Anti-Glioblastoma Activity. Biomolecules, 15(10), . https://doi.org/10.3390/biom15101470
Chicago Style (17th ed.) CitationM, Feldman, Rotenberg N, and Shifman JM. "Engineered N-TIMP2 Variant Specifically Targeting MMP-9 Exhibits Potent Anti-Glioblastoma Activity." Biomolecules 15, no. 10 (2025). https://doi.org/10.3390/biom15101470.
MLA (9th ed.) CitationM, Feldman, et al. "Engineered N-TIMP2 Variant Specifically Targeting MMP-9 Exhibits Potent Anti-Glioblastoma Activity." Biomolecules, vol. 15, no. 10, 2025, https://doi.org/10.3390/biom15101470.
Warning: These citations may not always be 100% accurate.